Clinical Comparison of Two Daily Disposable Contact Lenses in a Population of Daily Disposable Contact Lens Wearers
NCT ID: NCT01233076
Last Updated: 2012-07-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2010-10-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nelfilcon A / Narafilcon B
Nelfilcon A worn first, with narafilcon B worn second. Each product worn bilaterally in a daily wear, daily disposable basis for one week.
Nelfilcon A contact lens
Commercially marketed, spherical contact lens for daily wear, daily disposable use
Narafilcon B contact lens
Commercially marketed (US), spherical contact lens for daily wear, daily disposable use
Narafilcon B / Nelfilcon A
Narafilcon B worn first, with nelfilcon A worn second. Each product worn bilaterally in a daily wear, daily disposable basis for one week.
Nelfilcon A contact lens
Commercially marketed, spherical contact lens for daily wear, daily disposable use
Narafilcon B contact lens
Commercially marketed (US), spherical contact lens for daily wear, daily disposable use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nelfilcon A contact lens
Commercially marketed, spherical contact lens for daily wear, daily disposable use
Narafilcon B contact lens
Commercially marketed (US), spherical contact lens for daily wear, daily disposable use
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to wear study lenses in the available powers from -1.00D to -6.00D.
Exclusion Criteria
* History of corneal or refractive surgery.
* Pre-existing ocular irritation that would preclude contact lens fitting.
* Currently enrolled in any clinical trial.
* Currently wearing DAILIES AquaComfort Plus or 1-DAY ACUVUE TruEye lenses.
* Monovision correction during the study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CIBA VISION
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-337-C-034
Identifier Type: -
Identifier Source: org_study_id